Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression profiles of T-cell acute lymphoblastic leukemia (T-ALL) cell lines with depletion or inhbiiton of cBAF complex [RNA-seq]

ABSTRACT: Expression profiles of T-cell acute lymphoblastic leukemia (T-ALL) cell lines with depletion or inhbiiton of cBAF complex [RNA-seq]

PROVIDER: PRJNA944552 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23854612.fastq.gz	Fastqsanger.gz
	SRR23854613.fastq.gz	Fastqsanger.gz
	SRR23854614.fastq.gz	Fastqsanger.gz
	SRR23854615.fastq.gz	Fastqsanger.gz
	SRR23854616.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 72

Similar Datasets

Expression profiles of T-cell acute lymphoblastic leukemia (T-ALL) cell lines with depletion or inhbiiton of cBAF complex [RNA-seq]

Project description:From comparative transcriptome analysis using RNA-seq of the cells with cBAF-targeting gRNA or inhibitor, we identified the genes regulated by cBAF complex in T-ALL cell lines

2023-11-04 | GSE227274 | GEO

Characterization of cBAF complex in T-cell acute lymphoblastic leukemia (T-ALL)

Project description:Characterization of cBAF complex in T-cell acute lymphoblastic leukemia (T-ALL)

| PRJNA944548 | ENA

Chromatin binding of RUNX1 in T-cell acute lymphoblastic leukemia (T-ALL) cells with depletion cBAF complex [ChIP-seq]

Project description:Using ChIP-seq of RUNX1 in the cells with cBAF-targeting gRNA, we identified RUNX1 binding chromain loci which is regulated by cBAF complex

2023-11-04 | GSE243007 | GEO

Chromatin accessibility of T-cell acute lymphoblastic leukemia (T-ALL) cells with depletion or inhbiiton of cBAF complex [ATAC-seq]

Project description:Using ATAC-seq of the cells with cBAF-targeting gRNA or inhibitor, we identified chromatin loci whose accessibility was regulated by cBAF complex

2023-11-04 | GSE227273 | GEO

Chromatin binding of RUNX1 in T-cell acute lymphoblastic leukemia (T-ALL) cells with depletion cBAF complex [ChIP-seq]

Project description:Chromatin binding of RUNX1 in T-cell acute lymphoblastic leukemia (T-ALL) cells with depletion cBAF complex [ChIP-seq]

| PRJNA1015715 | ENA

Chromatin accessibility of T-cell acute lymphoblastic leukemia (T-ALL) cells with depletion or inhbiiton of cBAF complex [ATAC-seq]

Project description:Chromatin accessibility of T-cell acute lymphoblastic leukemia (T-ALL) cells with depletion or inhbiiton of cBAF complex [ATAC-seq]

| PRJNA944551 | ENA

Effect of BCAT1 depletion on sensitivity to Etoposide in T-cell acute lymphoblastic leukemia cells

Project description:High levels of branched-chain amino acid (BCAA) transaminase 1 (Bcat1) have been associated with adverse prognosis and drug resistance in several cancer types. However, the mechanistic role of Bcat1 in T-cell acute lymphoblastic leukemia (T-ALL) development is ill defined.We determined the effects of BCAT1 depletion on cellular sensitivity to DNA damaging agents (etoposide).

2025-01-02 | GSE275161 | GEO

Metabolomics of B-cell Acute Lymphoblastic Leukemia in Response to Adipocyte Conditioned Media

Project description:Adipocyte conditioned media (ACM), stromal cell conditioned media (SCM) and unconditioned media (UCM) were added to B-cell Acute Lymphoblastic Leukemia cells (REH and RCH-AcV) either with or without methotrexate (MTX). The metabolomic profiles of the cells was determined by mass spectrometry.

2022-10-07 | ST002383 | MetabolomicsWorkbench

Targeting the vulnerability to NAD+ depletion in B-cell acute lymphoblastic leukemia

Project description:Although substantial progress has been made in the treatment of B-cell acute lymphoblastic leukemia (B-ALL), the prognosis of patients with refractory or relapsed B-ALL remains dismal. Novel therapeutic strategies are needed to improve the outcome of these patients. KPT-9274 is a novel dual inhibitor of p21-activated kinase 4 (PAK4) and nicotinamide phosphoribosyltransferase (NAMPT). PAK4 is a serine/threonine kinases and it regulates a variety of protein kinases involved in cell survival, motility and proliferation. NAMPT is a rate-limiting enzyme in the salvage biosynthesis pathway of nicotinamide adenine dinucleotide (NAD), which plays a vital role in energy metabolism. Here, we show that KPT-9274 strongly inhibits B-ALL cell growth regardless of cytogenetic abnormalities. We also demonstrate the potent in vivo efficacy and tolerability of KPT-9274 in orthotopic xenograft murine models using patient-derived BALL cells. Although KPT-9274 affected both PAK4 signaling pathways and NAD+ dependent pathways, B-ALL cell growth inhibition mediated by KPT-9274 was largely abolished by nicotinic acid supplementation, indicating that the inhibitory effect of KPT- 9274 on B-ALL cell growth was mainly exerted by NAD+ depletion through blockade of NAMPT enzyme activity. Moreover, we found that B-ALL cells were especially vulnerable to NAD+ depletion, and the susceptibility to treatment with KPT-9274 was related to the reduced NAD+ reserve in B-ALL cells. NAD+ depletion may be a promising alternative approach to treating patients with B-ALL.

2017-05-01 | GSE86871 | GEO

Characterization of cBAF complex in T-cell acute lymphoblastic leukemia (T-ALL)

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-11-04 | GSE227275 | GEO